Vytrus Biotech (private company)

Vytrus Biotech was foundedx as Phyture Biotech, a spin-off company of the Faculty of Pharmacy at the Universitat de Barcelona, from a research group with more than 40 years of experience in the technology of plant cell cultures. On 2011 we launched the company's first cosmetic ingredient, and in 2013, the first medical device, based in the plant cell cultures technology, and pioneer in the Spanish market.

Companies with similar profile to Vytrus Biotech:

Company	Criteria
Scandinavian Real Hearts 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Sigrid Therapeutics 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Algenex 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
ARTHEx Biotech S.L. 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Pulmobiotics S.L 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Biograil 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Oncoheroes Biosciences 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Sooma Medical 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Cirqle Biomedical 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
ViveBiotech 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD Minim one investor from outside Scandinavia: Yes
Alvotech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
SonoClear 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD
APIM Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD
AFYX Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
DelSiTech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD
Sanifit Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
InProTher 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD
Tenboron 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 1M - 5M USD
Optomed 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
NMD Pharma 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes